Paediatrics

Letter: Reduced Risk of Neurodevelopmental and Psychiatric Disorders With Dupilumab Use in Pediatric Atopic Dermatitis

September 3, 2025 September 3, 2025

Dermatitis. 2025 Sep 3. doi: 10.1177/17103568251376644. Online ahead of print.

NO ABSTRACT

PMID:40899320 | DOI:10.1177/17103568251376644

John Joseph

JohnJAcademy.com

View all posts by John Joseph